Research News and Research

RSS

Finger nails on chalkboard - why so disturbing

The frequency of the screechy, scratchy sound ranges between 2000 and 4000 Hz, a frequency most sensitive to the human ear. “Some frequencies are amplified due to the anatomy of the ear canal,” write musicologists Christoph Reuter, of the University of Vienna, and Michael Oehler, of the Macromedia University for Media and Communication in Cologne, Germany.

7 Nov 2011

U.N. agencies respond to flooding in Horn of Africa

The U.N. High Commissioner for Refugees "reports heavy rains and flooding in parts of Somalia, Kenya and Ethiopia are causing havoc among thousands of displaced Somalis in the region" and "flood-damaged roads are hampering relief efforts to thousands affected by the heavy rains," VOA News reports.

7 Nov 2011

Medicare touts progress on closing doughnut hole

Meanwhile, MedPAC makes recommendations for controlling costs for "dual eligibles," and Medicare sees new rules bring costs down for weight loss surgery.

7 Nov 2011

Malpractice charges work way slowly through legal system, if at all

As hospitals and doctors try to implement new ways of preventing lawsuits, scrutiny of the system continues around the country.

7 Nov 2011

States trying to wrangle Medicaid costs, with some unintended consequences

Wisconsin is not alone in dealing with the thorny task of trying to lower the cost of its health care programs for low-income residents. Massachusetts no longer pays for restorative dental care and dentures. Washington no longer covers eyeglasses and hearing aids. Minnesota no long covers chiropractic care. … Every state plans to implement at least one policy to control Medicaid spending this fiscal year.

7 Nov 2011

Insurance Commissioners delay vote on brokers' fees

The National Association Of Insurance Commissioners meeting could not come to a consensus on the issue of whether to remove broker and agent fees from the expenses that insurance companies can count as administrative costs under the health law. In the meantime, GOP lawmakers have asked the IRS commissioner to clarify that individuals in state exchanges get any tax credits created under the new law.

7 Nov 2011

Blue Shield of Calif. turns to retail stores; Poll finds workers' share of health costs growing

Insurer's retail outlet in San Francisco will be in a supermarket. Meanwhile, a poll of large U.S. employer health spending by Modern Healthcare finds workers' costs are increasing.

7 Nov 2011

Proposals to raise Medicare age could raise costs too

NPR reports that raising the Medicare age could shift higher health care costs to others instead of saving money, while some lawmakers send a letter to the super committee opposing changing the tax exclusion for employer-sponsored health care.

7 Nov 2011

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

Gilead Sciences, Inc. and the Cardiovascular Research Foundation (CRF) today announced the initiation of RIVER-PCI (Ranolazine for Incomplete VEssel Revascularization post-PCI), a Phase 3 clinical trial evaluating the utility of ranolazine to prevent major adverse cardiovascular events (MACE) in patients with a history of chronic angina who have incomplete revascularization following percutaneous coronary intervention (PCI).

7 Nov 2011

Groups sound off on exchanges as governors wrestle with HHS over control

The issue of shaping health insurance exchanges is raising controversy even as states worry they'll bear the brunt of the public's anger over the law.

7 Nov 2011

Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven by the launches of several promising emerging therapies, the prostate cancer drug market will experience robust growth over the next decade, increasing from $3.6 billion in 2010 to $10.1 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

7 Nov 2011

Abortion and 'personhood' on GOP campaign agenda

State-level initiatives to restrict access to abortions help make social issues a major focus of the Republican presidential nomination contest.

7 Nov 2011

NanoString closes $20M Series D round of equity financing

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing.

From NanoString Technologies 7 Nov 2011

A.P. Pharma's third quarter net loss increases to $4.2 million

A.P. Pharma, Inc., a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2011 and highlighted its recent corporate progress.

7 Nov 2011

NewCardio's automated cardiac safety solution selected by top pharma company for Phase I drug study

NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that a top 5 global pharmaceutical company has selected QTinno, their automated cardiac safety solution, for an upcoming Phase I drug safety study.

7 Nov 2011

Pharmacyclics first quarter GAAP net loss increases to $14.5M

Pharmacyclics, Inc. today reported financial results and recent developments for its fiscal first quarter ended September 30, 2011.

7 Nov 2011

Neogen's new Soleris test detects yeast and mold in 48 hours

Neogen Corporation has developed an even quicker method to rapidly and accurately detect yeast and mold in food products. Neogen's new Soleris® test detects yeast and mold in 48 hours or less — conventional methods take up to 5 days.

7 Nov 2011

Gifts established at Case Western Reserve to educate physicians in integrative oncology

Case Western Reserve University School of Medicine is honored to announce gifts to establish the inaugural Parker Hannifin - Helen Moss Cancer Research Foundation Professorship in Integrative Oncology. This professorship will establish the School of Medicine and its affiliate hospitals as national leaders in teaching, research, and patient care in the field of integrative oncology.

7 Nov 2011

ACADIA and Meiji Seika collaborate to develop AM-831 for schizophrenia treatment

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.

7 Nov 2011

InfraReDx TVC Imaging System to be exhibited at TCT 2011

InfraReDx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced that its TVC Imaging System for the true vessel characterization of coronary artery disease will be highlighted during the annual Transcatheter Cardiovascular Therapeutics Meeting (TCT 2011).

7 Nov 2011